Published in J Virol on July 13, 2011
At the centre: influenza A virus ribonucleoproteins. Nat Rev Microbiol (2014) 1.33
The influenza A virus PB2, PA, NP, and M segments play a pivotal role during genome packaging. J Virol (2012) 1.12
A comprehensive map of the influenza A virus replication cycle. BMC Syst Biol (2013) 0.93
Transport of the influenza virus genome from nucleus to nucleus. Viruses (2013) 0.91
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugs. J Prev Med Hyg (2014) 0.86
The Feat of Packaging Eight Unique Genome Segments. Viruses (2016) 0.77
ITGB5 and AGFG1 variants are associated with severity of airway responsiveness. BMC Med Genet (2013) 0.76
The temporally controlled expression of Drongo, the fruit fly homolog of AGFG1, is achieved in female germline cells via P-bodies and its localization requires functional Rab11. RNA Biol (2016) 0.75
Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene (1991) 38.64
Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A (1999) 14.90
Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell (1991) 4.97
The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export. Curr Biol (1997) 4.35
Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell (2010) 4.33
The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J (1998) 3.98
Mechanisms of receptor-mediated nuclear import and nuclear export. Traffic (2005) 3.83
Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Cell (1995) 3.55
RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc Natl Acad Sci U S A (2003) 3.48
Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks. J Virol (1997) 3.00
A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature (1995) 2.98
Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway. J Virol (2001) 2.76
Role of the AP2 beta-appendage hub in recruiting partners for clathrin-coated vesicle assembly. PLoS Biol (2006) 2.71
Nuclear import and export of influenza virus nucleoprotein. J Virol (1997) 2.69
Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1. EMBO J (2000) 2.54
The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. J Biol Chem (1997) 2.42
Endocytosis of influenza viruses. Microbes Infect (2004) 2.38
Role of Unc51.1 and its binding partners in CNS axon outgrowth. Genes Dev (2004) 2.34
A role for RanBP1 in the release of CRM1 from the nuclear pore complex in a terminal step of nuclear export. J Cell Biol (1999) 2.27
Crystal structure of the M1 protein-binding domain of the influenza A virus nuclear export protein (NEP/NS2). EMBO J (2003) 1.95
EHD proteins: key conductors of endocytic transport. Trends Cell Biol (2010) 1.82
Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins. J Virol (2000) 1.78
Molecular basis for the sorting of the SNARE VAMP7 into endocytic clathrin-coated vesicles by the ArfGAP Hrb. Cell (2008) 1.75
The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathog (2010) 1.73
Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence. Proc Natl Acad Sci U S A (2010) 1.56
A Rab11- and microtubule-dependent mechanism for cytoplasmic transport of influenza A virus viral RNA. J Virol (2011) 1.52
Inhibition of nuclear export of ribonucleoprotein complexes of influenza virus by leptomycin B. Virus Res (2001) 1.41
ELMOD2 is an Arl2 GTPase-activating protein that also acts on Arfs. J Biol Chem (2007) 1.31
Budding of filamentous and non-filamentous influenza A virus occurs via a VPS4 and VPS28-independent pathway. Virology (2009) 1.31
RAB11A is essential for transport of the influenza virus genome to the plasma membrane. J Virol (2011) 1.29
Role of HRB in clathrin-dependent endocytosis. J Biol Chem (2008) 1.28
Nuclear export of influenza virus ribonucleoproteins: identification of an export intermediate at the nuclear periphery. Virology (2001) 1.28
Catalytic domain of the p120 Ras GAP binds to RAb5 and stimulates its GTPase activity. J Biol Chem (1998) 1.24
Putative reaction intermediates in Crm1-mediated nuclear protein export. J Biol Chem (1999) 1.24
hRIP, a cellular cofactor for Rev function, promotes release of HIV RNAs from the perinuclear region. Genes Dev (2003) 1.23
Visualization of microtubule-mediated transport of influenza viral progeny ribonucleoprotein. Microbes Infect (2007) 1.19
Abortive replication of influenza virus A/WSN/33 in HeLa229 cells: defective viral entry and budding processes. Virology (1994) 1.16
The eps15 homology (EH) domain-based interaction between eps15 and hrb connects the molecular machinery of endocytosis to that of nucleocytosolic transport. J Cell Biol (1999) 1.09
Crucial role of the influenza virus NS2 (NEP) C-terminal domain in M1 binding and nuclear export of vRNP. FEBS Lett (2010) 1.05
Influenza virus budding does not require a functional AAA+ ATPase, VPS4. Virus Res (2010) 0.97
The cellular HIV-1 Rev cofactor hRIP is required for viral replication. Proc Natl Acad Sci U S A (2005) 0.95
Nuclear export of influenza viral ribonucleoprotein is temperature-dependently inhibited by dissociation of viral matrix protein. Virology (2003) 0.93
HIV-1 Rev-binding protein accelerates cellular uptake of iron to drive Notch-induced T cell leukemogenesis in mice. J Clin Invest (2010) 0.84
In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature (2009) 14.59
Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature (2012) 14.17
Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature (2009) 11.34
Avian flu: influenza virus receptors in the human airway. Nature (2006) 11.28
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature (2007) 10.40
Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet (2004) 8.62
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature (2006) 7.56
Avian flu: isolation of drug-resistant H5N1 virus. Nature (2005) 6.66
Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature (2004) 6.11
PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice. Virology (2004) 5.96
Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol (2005) 5.28
Properties and dissemination of H5N1 viruses isolated during an influenza outbreak in migratory waterfowl in western China. J Virol (2006) 5.26
Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature (2006) 4.52
Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog (2007) 4.49
Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses. J Virol (2009) 4.20
Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature (2008) 4.18
Inhibition of Lassa and Marburg virus production by tetherin. J Virol (2008) 3.98
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol (2010) 3.77
Characterization of H7N9 influenza A viruses isolated from humans. Nature (2013) 3.71
Gain-of-function experiments on H7N9. Science (2013) 3.67
Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS Pathog (2010) 3.65
Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol (2002) 3.62
The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science (2012) 3.50
Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci U S A (2003) 3.45
Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis (2006) 3.27
The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell (2013) 3.19
Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA (2007) 3.00
The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu Rev Microbiol (2005) 2.89
A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J Virol (2007) 2.80
Characterization of H5N1 influenza A viruses isolated during the 2003-2004 influenza outbreaks in Japan. Virology (2005) 2.77
Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin Infect Dis (2006) 2.72
Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions. J Virol (2006) 2.70
Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes. J Virol (2003) 2.67
Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog (2009) 2.62
Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication. J Virol (2006) 2.60
Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog (2010) 2.60
Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol (2002) 2.58
Human infection with highly pathogenic H5N1 influenza virus. Lancet (2008) 2.57
Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor. J Clin Microbiol (2005) 2.55
Importance of both the coding and the segment-specific noncoding regions of the influenza A virus NS segment for its efficient incorporation into virions. J Virol (2005) 2.45
Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog (2009) 2.44
Molecular determinants of Ebola virus virulence in mice. PLoS Pathog (2006) 2.44
Selection of H5N1 influenza virus PB2 during replication in humans. J Virol (2009) 2.42
Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol (2004) 2.34
An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. Proc Natl Acad Sci U S A (2005) 2.33
Avian flu: Gain-of-function experiments on H7N9. Nature (2013) 2.32
High level of genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses. J Virol (2010) 2.29
Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol (2006) 2.24
Pause on avian flu transmission research. Science (2012) 2.24
Differences in cytokine production in human macrophages and in virulence in mice are attributable to the acidic polymerase protein of highly pathogenic influenza A virus subtype H5N1. J Infect Dis (2012) 2.24
Cellular networks involved in the influenza virus life cycle. Cell Host Microbe (2010) 2.23
Nedd4 regulates egress of Ebola virus-like particles from host cells. J Virol (2003) 2.19
Characterization of a human H5N1 influenza A virus isolated in 2003. J Virol (2005) 2.09
Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics. J Virol (2004) 2.09
The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly. J Virol (2006) 2.07
An infectious disease of ducks caused by a newly emerged Tembusu virus strain in mainland China. Virology (2011) 2.05
A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection. Proc Natl Acad Sci U S A (2009) 2.04
Cellular factors required for Lassa virus budding. J Virol (2006) 2.02
Ebola virus VP40 late domains are not essential for viral replication in cell culture. J Virol (2005) 1.97
The pathogenesis of influenza virus infections: the contributions of virus and host factors. Curr Opin Immunol (2011) 1.95
High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza. J Infect Dis (2003) 1.89
Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev Med Virol (2003) 1.88
The role of receptor binding specificity in interspecies transmission of influenza viruses. Curr Opin Virol (2012) 1.84
A shared structural solution for neutralizing ebolaviruses. Nat Struct Mol Biol (2011) 1.84
Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates. Proc Natl Acad Sci U S A (2013) 1.81
A naturally occurring deletion in its NS gene contributes to the attenuation of an H5N1 swine influenza virus in chickens. J Virol (2007) 1.80
Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. Vaccine (2003) 1.78
Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses. J Virol (2003) 1.78
Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proc Natl Acad Sci U S A (2011) 1.73
H5N1 influenza viruses: outbreaks and biological properties. Cell Res (2009) 1.72
Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children. Clin Infect Dis (2008) 1.72
Pause on avian flu transmission studies. Nature (2012) 1.71
Influenza A (H5N1) viruses from pigs, Indonesia. Emerg Infect Dis (2010) 1.70
Functional mapping of the nucleoprotein of Ebola virus. J Virol (2006) 1.69
Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses. PLoS Pathog (2010) 1.65
H6 influenza viruses pose a potential threat to human health. J Virol (2014) 1.64
Three-dimensional analysis of ribonucleoprotein complexes in influenza A virus. Nat Commun (2012) 1.64
Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1. Nature (2010) 1.63
Assembly and budding of Ebolavirus. PLoS Pathog (2006) 1.62
Antibody-dependent enhancement of Ebola virus infection. J Virol (2003) 1.62
A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned? J Gen Virol (2002) 1.60
Structural rearrangement of ebola virus VP40 begets multiple functions in the virus life cycle. Cell (2013) 1.59
Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence. Proc Natl Acad Sci U S A (2010) 1.56
Two amino acid residues in the matrix protein M1 contribute to the virulence difference of H5N1 avian influenza viruses in mice. Virology (2008) 1.55
Compatibility among polymerase subunit proteins is a restricting factor in reassortment between equine H7N7 and human H3N2 influenza viruses. J Virol (2008) 1.55
Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA. J Virol Methods (2010) 1.53